MICRO-X LIMITED — Capital/Financing Update 2016

Aug 28, 2016

Micro-X Limited, 1284 South Road, Tonsley, Clovelly Park, South Australia, 5042

==> picture [127 x 37] intentionally omitted <==

ABN: 21 153 273 735

Monday 29[th] August 2016

ASX Announcement – MICRO-X LIMITED (ASX: MX1)

Micro-X and Carestream Sign Development and Supply Agreements

Micro-X Limited is pleased to announce that it has signed agreements with Carestream Health Inc. for exclusive development and OEM supply of a mobile medical X-ray unit which Carestream will market when the product becomes commercially available.

“We have enjoyed an exceptional relationship with the Carestream team over the last three years as we developed a portable X-ray unit that will expand Carestream’s medical imaging portfolio. As a market leader in mobile X-ray systems, Carestream has provided valuable insight into end users’ needs and global market requirements,” said Peter Rowland, Managing Director of Micro-X. “With the product development phase now completed, we’re excited by the upcoming commercial potential of this system and are confident this new product will achieve strong user acceptance.”

When available, Carestream intends to offer this portable X-ray unit for sale through its direct sales team as well as its network of dealers and distributors.

“Our vision for this product has remained unchanged since Micro-X first approached Carestream to partner with us on the program. We have a solid reputation for providing customers around the world with outstanding digital X-ray solutions, and we believe this proprietary technology will complement our marketleading mobile digital product suite and further enhance our reputation for innovation,” said Jianqing Bennett, President of Carestream’s Digital Medical Solutions business.

Micro-X anticipates receipt of purchase orders for pre-production units in the coming months, which will be used by Carestream for sales, marketing and customer support training, as well as customer trade trials. The supply agreement has a term of five years with an option for ongoing renewals annually thereafter.

Following recent successful preliminary testing of prototype units, Micro-X will commence full verification and validation testing next month on pre-production units needed for both FDA 510(k) submission and the EU Medical Device Directive’s Declaration of Conformity.

For further information please contact: Mr Peter Rowland, Managing Director, Micro-X Limited

Telephone: +61 418 844 981 prowland@micro-x.com www.micro-x.com

About Micro-X : Micro-X Limited (“ MX1 ”) is an Australian Securities Exchange listed company developing and commercialising a range of highly innovative products based on proprietary carbon nanotube emitter technologies exclusively licensed and sourced from XinRay Systems Inc., a US based technology developer. These technologies enable the miniaturisation of a number of X-ray applications relevant to large global markets.